Progyny Inc (PGNY)

Currency in USD
22.85
-0.21(-0.91%)
Closed·
After Hours
22.850.00(0.00%)
·
PGNY Scorecard
Full Analysis
Management has been aggressively buying back shares
Unusual trading volume
PGNY is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
21.7026.38
52 wk Range
13.3926.76
Key Statistics
Prev. Close
23.06
Open
26.21
Day's Range
21.7-26.38
52 wk Range
13.39-26.76
Volume
2.66M
Average Volume (3m)
1.13M
1-Year Change
5.74%
Book Value / Share
6.01
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
PGNY Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
27.13
Upside
+18.71%
Members' Sentiments
Bearish
Bullish
ProTips
Holds more cash than debt on its balance sheet

Progyny Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Progyny Inc Company Profile

Progyny, Inc., a benefits management company, provides fertility, family building, and women’s health benefits solutions in the United States. The company offers fertility benefits solutions, such as differentiated benefits plan design that includes smart cycle treatment bundle; personalized concierge-style member support services; and a selective network of fertility specialists. It also offers Progyny Rx, an integrated pharmacy benefits solution that provides access to the medications needed during their treatment and offers care management services. In addition, the company offers assistance service program where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.

Progyny Inc SWOT Analysis


Market Dynamics
Explore Progyny's position in the expanding fertility benefits market, projected to reach $50 billion by 2030, and its innovative approach to comprehensive coverage
Financial Challenges
Delve into Progyny's recent setbacks, including the loss of a major client and lowered revenue guidance, balanced against its strong cash position and profitability
Strategic Expansion
Learn about Progyny's foray into maternity and menopause programs, potentially offsetting recent losses and contributing significantly to future revenue growth
Analyst Outlook
Discover varied analyst perspectives, with price targets ranging from $22 to $30, reflecting both optimism about long-term potential and concerns over near-term headwinds
Read full SWOT analysis

Progyny Inc Earnings Call Summary for Q2/2025

  • Progyny Q2 2025 adjusted EPS of $0.48 beat forecasts by 200%, with revenue up 9.5% YoY to $332.9 million
  • Despite strong results, stock fell 1.83% in aftermarket trading to $23.06
  • Company expanded product offerings and global services, anticipating continued client base and covered lives growth
  • Full-year revenue projected at $1.235-$1.270 billion, with adjusted EBITDA of $205.5-$214.5 million
  • Management highlighted client diversity as key strength, with 81% of HR leaders committed to advancing women's health
Last Updated: 08/08/2025, 11:56
Read Full Transcript

Compare PGNY to Peers and Sector

Metrics to compare
PGNY
Peers
Sector
Relationship
P/E Ratio
36.7x−0.1x−0.5x
PEG Ratio
−5.020.040.00
Price/Book
3.8x0.8x2.6x
Price / LTM Sales
1.6x0.9x3.3x
Upside (Analyst Target)
24.7%43.6%43.4%
Fair Value Upside
Unlock14.6%7.1%Unlock

Analyst Ratings

5 Buy
5 Hold
0 Sell
Ratings:
10 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 27.13
(+18.71% Upside)

Earnings

Latest Release
Aug 07, 2025
EPS / Forecast
0.48 / 0.16
Revenue / Forecast
332.84M / 317.61M
EPS Revisions
Last 90 days

PGNY Income Statement

People Also Watch

179.28
ALAB
+4.91%
317.66
ZBRA
+0.52%
159.03
CRCL
+3.99%
25.59
CNC
+1.31%
32.02
YOU
+0.28%

FAQ

What Stock Exchange Does Progyny Trade On?

Progyny is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for Progyny?

The stock symbol for Progyny is "PGNY."

What Is the Progyny Market Cap?

As of today, Progyny market cap is 1.95B.

What Is Progyny's Earnings Per Share (TTM)?

The Progyny EPS (TTM) is 0.61.

When Is the Next Progyny Earnings Date?

Progyny will release its next earnings report on 29 Oct 2025.

From a Technical Analysis Perspective, Is PGNY a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Progyny Stock Split?

Progyny has split 0 times.

How Many Employees Does Progyny Have?

Progyny has 678 employees.

What is the current trading status of Progyny (PGNY)?

As of 10 Aug 2025, Progyny (PGNY) is trading at a price of 22.85, with a previous close of 23.06. The stock has fluctuated within a day range of 21.70 to 26.38, while its 52-week range spans from 13.39 to 26.76.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.